IN202121042020A - - Google Patents

Download PDF

Info

Publication number
IN202121042020A
IN202121042020A IN202121042020A IN202121042020A IN202121042020A IN 202121042020 A IN202121042020 A IN 202121042020A IN 202121042020 A IN202121042020 A IN 202121042020A IN 202121042020 A IN202121042020 A IN 202121042020A IN 202121042020 A IN202121042020 A IN 202121042020A
Authority
IN
India
Application number
IN202121042020A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN202121042020A priority Critical patent/IN202121042020A/en
Priority to CA3229273A priority patent/CA3229273A1/fr
Priority to PCT/IB2022/058697 priority patent/WO2023042107A1/fr
Priority to AU2022347385A priority patent/AU2022347385A1/en
Publication of IN202121042020A publication Critical patent/IN202121042020A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN202121042020A 2021-09-17 2021-09-17 IN202121042020A (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN202121042020A IN202121042020A (fr) 2021-09-17 2021-09-17
CA3229273A CA3229273A1 (fr) 2021-09-17 2022-09-15 Formulation pharmaceutique injectable, stable et prete a diluer de mitomycine
PCT/IB2022/058697 WO2023042107A1 (fr) 2021-09-17 2022-09-15 Formulation pharmaceutique injectable, stable et prête à diluer de mitomycine
AU2022347385A AU2022347385A1 (en) 2021-09-17 2022-09-15 A stable ready to dilute injectable pharmaceutical formulation of mitomycin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN202121042020A IN202121042020A (fr) 2021-09-17 2021-09-17

Publications (1)

Publication Number Publication Date
IN202121042020A true IN202121042020A (fr) 2023-03-24

Family

ID=85602499

Family Applications (1)

Application Number Title Priority Date Filing Date
IN202121042020A IN202121042020A (fr) 2021-09-17 2021-09-17

Country Status (4)

Country Link
AU (1) AU2022347385A1 (fr)
CA (1) CA3229273A1 (fr)
IN (1) IN202121042020A (fr)
WO (1) WO2023042107A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024079565A1 (fr) * 2022-10-12 2024-04-18 Harshal Prabhakar Bhagwatwar Concentrés stables de mitomycine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630168B1 (en) * 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
DE19957371A1 (de) * 1999-11-29 2001-06-13 Medac Klinische Spezialpraep Mitomycin C-Lösung
ES2648367T3 (es) * 2013-10-22 2018-01-02 Medac Gesellschaft für klinische Spezialpräparate mbH Procedimiento de preparación de una composición farmacéutica liofilizada que contiene mitomicina C

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024079565A1 (fr) * 2022-10-12 2024-04-18 Harshal Prabhakar Bhagwatwar Concentrés stables de mitomycine

Also Published As

Publication number Publication date
WO2023042107A1 (fr) 2023-03-23
AU2022347385A1 (en) 2024-02-22
CA3229273A1 (fr) 2023-03-23

Similar Documents

Publication Publication Date Title
BR112023005462A2 (fr)
BR112021014123A2 (fr)
BR112023012656A2 (fr)
BR112022009896A2 (fr)
BR112022024743A2 (fr)
BR112023009656A2 (fr)
BR102021018859A2 (fr)
BR102021015500A2 (fr)
BR102021007058A2 (fr)
BR102020022030A2 (fr)
BR112023011738A2 (fr)
BR112023016292A2 (fr)
BR112023004146A2 (fr)
BR112023011610A2 (fr)
BR112023011539A2 (fr)
BR112023008976A2 (fr)
BR112023006729A2 (fr)
BR102021020147A2 (fr)
BR102021018926A2 (fr)
BR102021018167A2 (fr)
BR102021017576A2 (fr)
BR102021016837A2 (fr)
BR102021016551A2 (fr)
BR102021016375A2 (fr)
BR102021016176A2 (fr)